These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2651297)
1. Transgenic mice in cancer research. Jenkins NA; Copeland NG Important Adv Oncol; 1989; ():61-77. PubMed ID: 2651297 [No Abstract] [Full Text] [Related]
2. [Development of animal models for carcinogenesis by transgenesis. Transgenic mouse models for cancer research]. Katsuki M Jikken Dobutsu; 1993 Jul; 42(3):281-2. PubMed ID: 8354348 [No Abstract] [Full Text] [Related]
3. [The patented oncomouse. Transgenic animals in medical research--knowledge and risks]. Hobom B Fortschr Med; 1989 Jun; 107(17):100-2. PubMed ID: 2744678 [No Abstract] [Full Text] [Related]
4. Transgenic cancer resistant mice carrying the E. coli O6-alkylguanine-DNA alkyltransferase gene, ada. Rajewsky MF Jpn J Cancer Res; 1993 Apr; 84(4):inside front cover. PubMed ID: 8514602 [No Abstract] [Full Text] [Related]
5. Transgenic mice in the study of development. DeLoia JA; Gearhart JD Mead Johnson Symp Perinat Dev Med; 1987; (29):41-6. PubMed ID: 3332906 [No Abstract] [Full Text] [Related]
6. The use of biotechnical recombinant-mice to test the safety of potential carcinogenic pharmaceuticals. Inoue T J Toxicol Sci; 1995 Sep; 20(4):468-70. PubMed ID: 8531244 [No Abstract] [Full Text] [Related]
9. Dissecting multistep tumorigenesis in transgenic mice. Hanahan D Annu Rev Genet; 1988; 22():479-519. PubMed ID: 3071256 [No Abstract] [Full Text] [Related]
10. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. Hanahan D; Wagner EF; Palmiter RD Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663 [TBL] [Abstract][Full Text] [Related]
11. Animal models and the molecular pathology of cancer. Lovejoy EA; Clarke AR; Harrison DJ J Pathol; 1997 Feb; 181(2):130-5. PubMed ID: 9120714 [No Abstract] [Full Text] [Related]
12. Molecular dissection of multi-stage tumorigenesis in transgenic mice. Christofori G; Hanahan D Semin Cancer Biol; 1994 Feb; 5(1):3-12. PubMed ID: 8186386 [TBL] [Abstract][Full Text] [Related]
13. Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. Merlino G Semin Cancer Biol; 1994 Feb; 5(1):13-20. PubMed ID: 8186384 [TBL] [Abstract][Full Text] [Related]
14. [Oncogenesis in transgenic mice]. Shvemberger IN; Ermilov AN Tsitologiia; 1994; 36(2):131-47. PubMed ID: 7809963 [TBL] [Abstract][Full Text] [Related]
15. Validation issues for the use of transgenic mouse mutation assays in risk assessment. Gorelick NJ Prog Clin Biol Res; 1996; 395():81-108. PubMed ID: 8895985 [No Abstract] [Full Text] [Related]
16. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Morgenbesser SD; DePinho RA Semin Cancer Biol; 1994 Feb; 5(1):21-36. PubMed ID: 8186385 [TBL] [Abstract][Full Text] [Related]